1. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019) Authors: Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Aragri, M.; Paolucci, S.; Masetti, C.; D'Ambrosio, R.; Degasperi, E.; Polilli, E.; Palitti, V. Pace; Fiorentino, G.; Foroghi, L.; Cento, V.; Scutari, R.; Bruzzone, B.; Calvaruso, V.; Coppola, N.; Gaeta, G.B.; Morsica, G.; Ghisetti, V. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life. Issue 1 (16th February 2017) Authors: Cento, V.; Barbaliscia, S.; Lenci, I.; Ruggiero, T.; Masetti, C.; Magni, C.F.; Micheli, V.; Paolucci, S.; Troshina, Y.; Biliotti, E.; Milana, M.; Melis, M.; Teti, E.; Lambiase, L.; Menzaghi, B.; Nicolini, L.A.; Marenco, S.; Di Maio, V.C.; Aragri, M.; Pecchioli, A. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies. Issue 1 (16th February 2017) Authors: Di Maio, V.C.; Cento, V.; Lenci, I.; Aragri, M.; Barbaliscia, S.; Francioso, S.; Paolucci, S.; Melis, M.; Verucchi, G.; Masetti, C.; Coppola, N.; Magni, C.F.; Micheli, V.; Pollicino, T.; Ruggiero, T.; Landonio, S.; Mancon, A.; Starace, M.; De Leonardis, F.; Santopaolo, F. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Natural HCV resistance is common in Italy and differently associated to genotypes. Issue 1 (16th February 2017) Authors: Sorbo, M.C.; Cento, V.; Bertoli, A.; Lenci, I.; Polilli, E.; Masetti, C.; Gianserra, L.; Teti, E.; Biliotti, E.; Magni, C.F.; Aragri, M.; Micheli, V.; Melis, M.; Nicolini, L.A.; Marenco, S.; Calvaruso, V.; Paolucci, S.; Baldanti, F.; Morisco, F.; Siciliano, M. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life. (October 2017) Authors: Cento, V.; Barbaliscia, S.; Lenci, I.; Ruggiero, T.; Magni, C.F.; Paolucci, S.; Babudieri, S.; Siciliano, M.; Pasquazzi, C.; Ciancio, A.; Perno, C.F.; Ceccherini-Silberstein, F. Journal: Clinical microbiology and infection Issue: Volume 23:Number 10(2017) Page Start: 777.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prevalence and characteristics of resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in Italy. Issue 1 (16th February 2017) Authors: Di Maio, V.C.; Barbaliscia, S.; Lenci, I.; Teti, E.; Antonucci, F.P.; Cento, V.; Aragri, M.; Paolucci, S.; Bruzzone, B.; Coppola, N.; Ruggiero, T.; Pollicino, T.; Polilli, E.; Pasquazzi, C.; Pace Palitti, V.; Magni, C.F.; Micheli, V.; Di Biagio, A.; Sticchi, L.; Melis, M. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network. Issue 1 (16th February 2017) Authors: Cento, V.; Barbaliscia, S.; Di Maio, V.C.; Masetti, C.; Minichini, C.; Magni, C.F.; Micheli, V.; Marenco, S.; Nicolini, L.A.; Bruzzone, B.; Troshina, Y.; Baiguera, C.; Dentone, C.; Calvaruso, V.; Paolucci, S.; Melis, M.; Aragri, M.; Bertoli, A.; Lenci, I.; Landonio, S. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy. (February 2019) Authors: Pasulo, L.; Gambato, M.; Spinetti, A.; D'Ambrosio, R.; Puoti, M.; Ciancio, A.; Di Marco, V.; Calvaruso, V.; Colombatto, P.; Brunetto, M.; Schiavini, M.; Fabris, P.; Sacchi, P.; Gulminetti, R.; Carolo, G.; Scotton, P.; Pozzan, C.; Vinci, M.; Viganò, M.; Lombardi, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗